DSGN
Price
$10.03
Change
-$0.34 (-3.28%)
Updated
Feb 4, 02:33 PM (EDT)
Capitalization
590.14M
41 days until earnings call
Intraday BUY SELL Signals
LCTX
Price
$1.72
Change
-$0.04 (-2.27%)
Updated
Feb 4, 02:57 PM (EDT)
Capitalization
405.38M
29 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs LCTX

Header iconDSGN vs LCTX Comparison
Open Charts DSGN vs LCTXBanner chart's image
Design Therapeutics
Price$10.03
Change-$0.34 (-3.28%)
Volume$327
Capitalization590.14M
Lineage Cell Therapeutics
Price$1.72
Change-$0.04 (-2.27%)
Volume$200
Capitalization405.38M
DSGN vs LCTX Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
LCTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. LCTX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and LCTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (DSGN: $10.37 vs. LCTX: $1.76)
Brand notoriety: DSGN and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 37% vs. LCTX: 192%
Market capitalization -- DSGN: $590.14M vs. LCTX: $405.38M
DSGN [@Biotechnology] is valued at $590.14M. LCTX’s [@Biotechnology] market capitalization is $405.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 4 TA indicator(s) are bullish while LCTX’s TA Score has 7 bullish TA indicator(s).

  • DSGN’s TA Score: 4 bullish, 3 bearish.
  • LCTX’s TA Score: 7 bullish, 1 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -2.08% price change this week, while LCTX (@Biotechnology) price change was +7.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

LCTX is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($590M) has a higher market cap than LCTX($405M). DSGN YTD gains are higher at: 10.554 vs. LCTX (5.389). LCTX has higher annual earnings (EBITDA): -19.68M vs. DSGN (-77.38M). DSGN has more cash in the bank: 206M vs. LCTX (40.5M). DSGN has less debt than LCTX: DSGN (1.74M) vs LCTX (2.62M). LCTX has higher revenues than DSGN: LCTX (10.8M) vs DSGN (0).
DSGNLCTXDSGN / LCTX
Capitalization590M405M146%
EBITDA-77.38M-19.68M393%
Gain YTD10.5545.389196%
P/E RatioN/AN/A-
Revenue010.8M-
Total Cash206M40.5M509%
Total Debt1.74M2.62M67%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
59
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNLCTX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
89%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 6 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
LCTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIRVX8.980.01
+0.11%
Goldman Sachs Intl Eq Div & Prem Inv
FSIDX18.25N/A
N/A
Fidelity Advisor Strategic Div & Inc I
VSCOX27.44-0.08
-0.29%
JPMorgan Small Cap Blend A
RPNLX13.19-0.22
-1.64%
RiverPark/Next Century Lg Gr Inst
DGLCX14.44-0.28
-1.90%
BNY Mellon Global Stock - C

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.38%
IDYA - DSGN
51%
Loosely correlated
+0.50%
DYN - DSGN
51%
Loosely correlated
+1.07%
SLDB - DSGN
50%
Loosely correlated
+1.71%
SYRE - DSGN
49%
Loosely correlated
+1.65%
VRDN - DSGN
49%
Loosely correlated
-3.92%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+14.29%
MDGL - LCTX
43%
Loosely correlated
-1.49%
VIR - LCTX
38%
Loosely correlated
-0.39%
RXRX - LCTX
36%
Loosely correlated
-1.91%
DSGN - LCTX
35%
Loosely correlated
-0.38%
ELVN - LCTX
34%
Loosely correlated
-2.02%
More